Royalty Pharma plc
Balance Sheet
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $2.11B | $1.79B | $1.54B | $1.80B | $1.14B | $708.8M | $1.01B | $1.55B |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $3.50B | $2.98B | $2.88B | $2.78B | $2.71B | $2.42B | $2.70B | $2.78B |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $0 | $0 | $5.7M | $11.5M | $17.3M | $23.0M | $28.7M | $34.5M |
| Total Assets | $17.74B | $17.38B | $17.52B | $17.73B | $16.51B | $15.91B | $16.02B | $15.99B |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $182.3M | $135.9M | $171.3M | $255.1M | $284.0M | $256.0M | $307.9M | $270.0M |
| Long-Term Debt | $7.11B | $7.10B | $7.10B | $7.09B | $5.83B | $5.82B | $5.82B | $5.81B |
| Total Liabilities | $7.33B | $7.24B | $7.27B | $7.35B | $6.11B | $6.08B | $6.12B | $6.19B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $2.45B | $2.22B | $2.26B | $2.32B | $2.29B | $1.92B | $1.92B | $1.81B |
| Total Stockholders' Equity | $10.41B | $10.14B | $10.25B | $10.39B | $10.41B | $9.84B | $9.90B | $9.80B |